Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Notification of major interests in shares

11th Oct 2010 14:30

RNS Number : 1948U
Immupharma PLC
11 October 2010
 



For immediate release

11 October 2010

 

Immupharma plc

 

TR-1: Notification of major interests in shares

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

 

Immupharma plc

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached.

 

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Full name of person(s) subject to the notification obligation:

Pictet Overseas Trust Corporation Limited

4. Full name of shareholder(s)  (if different from 3.):

See Above

 

5. Date of the transaction and date on which the threshold is crossed or reached:

 

6th October 2010

6. Date on which issuer notified:

7th October 2010

7. Threshold(s) that is/are crossed or reached:

 

3%

 

8. Notified details:

 

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Indirect

Direct

Indirect

 

Ordinary Shares GB0033711010

2,020,000

2,020,000

2,461,000

2,461,000

0

3.02%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial instrument

 

Expiration date

 

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

 

% of voting rights

N/A

N/A

N/A

N/A

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial instrument

 

 

Exercise price

 

Expiration date

 

Exercise/ Conversion period

 

Number of voting rights instrument refers to

 

 

% of voting rights

 

N/A

N/A

N/A

N/A

 

N/A

 

Nominal

Delta

N/A

N/A

Total (A+B+C)

Number of voting rights

Percentage of voting rights

2,461,000

3.02%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:xxi

 

N/A

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

Not Applicable

14. Contact name:

Katrina Montgomery, Legal & Compliance, Pictet Overseas Trust Corporation Limited

15. Contact telephone number:

+1 242 302 22 22

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLXFLFFBBFBFBZ

Related Shares:

Immupharma
FTSE 100 Latest
Value8,871.31
Change61.57